Case Reports
doi: 10.1081/jdi-120005372.
Mitomycin-C induced hemolytic uremic syndrome: a case report
Affiliations
- PMID: 12166705
- DOI: 10.1081/jdi-120005372
Item in Clipboard
Case Reports
Mitomycin-C induced hemolytic uremic syndrome: a case report
Ren Fail.
2002 May.
Free article
Abstract
Mitomycin-C is used widely in the treatment of malignancies and is associated with serious dose related adverse effects including the occurrence of hemolytic uremic syndrome. We report a patient with a colonic adenocarcinoma who developed hemolytic uremic syndrome after receiving 85 mg/m2 of the drug. The patient was left untreated and died 5 months after this diagnosis was made, of a second malignancy. Differential diagnosis and treatment of this condition are discussed.
Similar articles
-
[Mitomycin-induced hemolytic uremia syndrome].Dtsch Med Wochenschr. 2004 Jul 2;129(27):1528; author reply 1528. doi: 10.1055/s-2004-828987. Dtsch Med Wochenschr. 2004. PMID: 15227598 German. No abstract available.
-
Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.Jpn J Clin Oncol. 1997 Apr;27(2):115-8. doi: 10.1093/jjco/27.2.115. Jpn J Clin Oncol. 1997. PMID: 9152802 Review.
-
Mitomycin C-related hemolytic uremic syndrome in cancer patients.Anticancer Drugs. 1998 Jun;9(5):433-5. doi: 10.1097/00001813-199806000-00010. Anticancer Drugs. 1998. PMID: 9660541
-
Erythropoietin is beneficial in mitomycin-induced hemolytic-uremic syndrome.Nephron. 2002 Jun;91(2):324-6. doi: 10.1159/000058411. Nephron. 2002. PMID: 12053072
-
Hemolytic uremic syndrome.Oncol Nurs Forum. 2008 Jul;35(4):593-6. doi: 10.1188/08.ONF.593-596. Oncol Nurs Forum. 2008. PMID: 18591164 Review. No abstract available.
Cited by
-
The haemotoxicity of mitomycin in a repeat dose study in the female CD-1 mouse.Int J Exp Pathol. 2005 Dec;86(6):415-30. doi: 10.1111/j.0959-9673.2005.00452.x. Int J Exp Pathol. 2005. PMID: 16309546 Free PMC article.
-
The Nephrotoxicity of Drugs Used in Causal Oncological Therapies.Curr Oncol. 2022 Dec 8;29(12):9681-9694. doi: 10.3390/curroncol29120760. Curr Oncol. 2022. PMID: 36547174 Free PMC article. Review.
-
Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C.Br J Cancer. 2003 Dec 15;89(12):2299-304. doi: 10.1038/sj.bjc.6601403. Br J Cancer. 2003. PMID: 14676810 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
